Abstract
Bacteriocins are ribosomal peptides with highly diverse structures, produced by some bacterial lineages. In the search for therapeutic alternatives against multidrug resistant (MDR) pathogens, the research on bacteriocins has increased in the scientific community, recently incorporating strategies based on genomics, proteomics, and genetic engineering. The biodiversity present in non-impa…